{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:19:29Z","timestamp":1793283569404,"version":"4.5.0"},"reference-count":32,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Musculoskelet Radiol"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic kidney disease (CKD) induces mineral and bone disorders (CKD-MBD) that affect calcium and phosphate metabolism. This review links pathophysiology, histologic aspects, and radiologic signs. CKD leads to bone lesions, namely renal osteodystrophy, which may combine low or high bone remodeling, impaired mineralization, and bone loss. CKD-MBD also comprises vascular calcifications, which, together with bone disease, lead to a high risk of cardiovascular events and osteoporotic fractures that increase both morbidity and mortality. Osteoporosis assessment is based on screening for classic risk factors and CKD-related factors (disease duration\/severity, transplantation history, dialysis vintage). Treatment of mineral disorders may combine serum phosphate lowering drugs, natural vitamin D or its 1-\u03b1 derivatives, or calcium-sensing receptor agonists. Treatment of osteoporosis is conventional in mild to moderate stages but more complex in severe CKD because evidence about the efficacy and safety of anti-osteoporosis drugs is scant.<\/jats:p>","DOI":"10.1055\/s-0043-1770353","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T22:30:30Z","timestamp":1695681030000},"page":"463-470","source":"Crossref","is-referenced-by-count":20,"title":["Bone and Chronic Kidney Disease"],"prefix":"10.1055","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2091-3961","authenticated-orcid":false,"given":"Marie-H\u00e9l\u00e8ne","family":"Lafage-Proust","sequence":"additional","affiliation":[{"name":"INSERM U1059 SAINBIOSE Universit\u00e9 Jean Monnet, Saint-Etienne, France"},{"name":"Service de Rhumatologie, CHU Saint-Etienne, Saint-Etienne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"issue":"S 04","key":"ref1","first-page":"S250","article-title":"Incidence of chronic kidney disease in the general population, EPIRAN study [in French]","volume":"5","author":"C Loos-Ayav","year":"2009","journal-title":"Nephrol Ther"},{"issue":"04","key":"ref2","first-page":"239","article-title":"Assessment and characteristics of chronic renal insufficiency in France [in French]","volume":"61","author":"V Bongard","year":"2012","journal-title":"Ann Cardiol Angeiol (Paris)"},{"issue":"05","key":"ref3","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","article-title":"A single number for advocacy and communication\u2014worldwide more than 850 million individuals have kidney diseases","volume":"96","author":"K J Jager","year":"2019","journal-title":"Kidney Int"},{"key":"ref5","first-page":"18","article-title":"Pr\u00e9valence de l'IRCT et part des diff\u00e9rentes modalit\u00e9s de traitement","volume":"x","author":"I Belkacem","year":"2022","journal-title":"Nephrol Ther"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"S Moe","year":"2006","journal-title":"Kidney Int"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1053\/j.ajkd.2013.12.016","article-title":"Fragility fractures and osteoporosis in CKD: pathophysiology and diagnostic methods","volume":"63","author":"S N Salam","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"115460","DOI":"10.1016\/j.bone.2020.115460","article-title":"Quantitative histomorphometric analysis of halved iliac crest bone biopsies yield comparable ROD diagnosis as full 7.5mm wide samples","volume":"138","author":"E Novel-Catin","year":"2020","journal-title":"Bone"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s40620-020-00798-x","article-title":"Iliac crest bone biopsy by interventional radiologists to improve access to bone biopsy in chronic kidney disease populations: technical note and a case series","volume":"34","author":"F Lavigne","year":"2021","journal-title":"J Nephrol"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","article-title":"Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis","volume":"67","author":"S M Sprague","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"05","key":"ref11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.ajkd.2021.07.027","article-title":"Diagnostic accuracy of noninvasive bone turnover markers in renal osteodystrophy","volume":"79","author":"H S J\u00f8rgensen","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"07","key":"ref12","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"M Jadoul","year":"2006","journal-title":"Kidney Int"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1681\/ASN.2005111194","article-title":"Relationship between moderate to severe kidney disease and hip fracture in the United States","volume":"17","author":"T L Nickolas","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"07","key":"ref14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00198-003-1435-y","article-title":"Relationship between age, renal function and bone mineral density in the US population","volume":"14","author":"S Klawansky","year":"2003","journal-title":"Osteoporos Int"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/ckj\/sfaa234","article-title":"The renal patient seen by non-renal physicians: the kidney embedded in the \u2018milieu int\u00e9rieur\u2019","volume":"14","author":"F Perez-Villa","year":"2020","journal-title":"Clin Kidney J"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s40620-017-0433-7","article-title":"The use of bone mineral density measured by dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed microtomography in chronic kidney disease","volume":"30","author":"M Jannot","year":"2017","journal-title":"J Nephrol"},{"issue":"07","key":"ref17","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2215\/CJN.12871211","article-title":"Bone mineral density and fracture risk in older individuals with CKD","volume":"7","author":"R H Yenchek","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2215\/CJN.06040614","article-title":"Comparison of fracture risk prediction among individuals with reduced and normal kidney function","volume":"10","author":"K L Naylor","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients\u2014a single-center cohort study","volume":"27","author":"S Iimori","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s00198-020-05458-1","article-title":"Trabecular bone score in patients with chronic kidney disease","volume":"31","author":"C Rampersad","year":"2020","journal-title":"Osteoporos Int"},{"issue":"06","key":"ref22","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/jbmr.3977","article-title":"Comparison of fracture prediction tools in individuals without and with early chronic kidney disease: a population-based analysis of CARTaGENE","volume":"35","author":"L C Desbiens","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.kint.2018.09.022","article-title":"The Fracture Risk Assessment Tool (FRAX\u00ae) predicts fracture risk in patients with chronic kidney disease","volume":"95","author":"R H Whitlock","year":"2019","journal-title":"Kidney Int"},{"issue":"06","key":"ref24","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2215\/CJN.02190507","article-title":"Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease","volume":"2","author":"M K Sigrist","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","article-title":"European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D","volume":"36","author":"P Evenepoel","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"ref26","first-page":"1608","article-title":"Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative\u2014a position paper","volume":"32","author":"P Evenepoel","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"822178","DOI":"10.3389\/fphar.2022.822178","article-title":"Efficacy of osteoporosis medications for patients with chronic kidney disease: an updated systematic review and network meta-analysis","volume":"13","author":"C H Chen","year":"2022","journal-title":"Front Pharmacol"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1359\/JBMR.050817","article-title":"Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials","volume":"20","author":"P D Miller","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00198-006-0189-8","article-title":"Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment","volume":"18","author":"P D Miller","year":"2007","journal-title":"Osteoporos Int"},{"issue":"07","key":"ref30","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1681\/ASN.2007050555","article-title":"The effect of raloxifene treatment in postmenopausal women with CKD","volume":"19","author":"A Ishani","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"02","key":"ref31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1210\/clinem\/dgaa851","article-title":"Denosumab safety and efficacy among participants in the FREEDOM extension study with mild to moderate chronic kidney disease","volume":"106","author":"A Broadwell","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"04","key":"ref32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00774-022-01332-8","article-title":"Efficacy and safety of romosozumab among Japanese postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease","volume":"40","author":"A Miyauchi","year":"2022","journal-title":"J Bone Miner Metab"},{"issue":"05","key":"ref33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jos.2016.05.004","article-title":"Effectiveness of kyphoplasty in the treatment of osteoporotic vertebral compression fracture patients with chronic kidney disease","volume":"21","author":"H Chen","year":"2016","journal-title":"J Orthop Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"115909","DOI":"10.1016\/j.bone.2021.115909","article-title":"Secular trends in hip fracture incidence and subsequent mortality in dialysis patients and the general population in Sweden","volume":"147","author":"K Iseri","year":"2021","journal-title":"Bone"}],"container-title":["Seminars in Musculoskeletal Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1770353.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T22:32:47Z","timestamp":1695681167000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1770353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":32,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2023,9,25]]},"published-print":{"date-parts":[[2023,8]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1770353","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1089-7860","1098-898X"],"issn-type":[{"value":"1089-7860","type":"print"},{"value":"1098-898X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]}}}